EquitAI LogoEquitAI
$151.00
-0.15%
GILD

GILD

Gilead Sciences, Inc.

Healthcare
Loading Chart...
FIT ANALYSIS
Required for personalization
STOCK DNA
Valuation
5/10
Quality
4/10
Growth
4/10
Strength
3/10
Dividend
6/10
Price Trend
Upwards
Momentum
Stretched
Balance Sheet
High Leverage
Earnings
Growth
Dividend Yield
2.17%
Market Cap
$187.23B
TALK TO YOUR STOCK
EQUITAI ASSISTANT

Gilead Sciences is a premier biopharmaceutical company that develops innovative medicines for life-threatening diseases. Its core products include blockbuster treatments for HIV, viral hepatitis, and a rapidly growing portfolio of targeted cancer therapies. I have synthesized my analysis of its core fundamentals, live market action, and peer metrics to provide a comprehensive thesis. What specific areas can I detail for you?

AI can make mistakes. Verify important information.
Talk to Your Stockopen live chat
Pro EquitAI Research
Retrieving premium status...